Results 141 to 150 of about 11,360 (208)

Antimalarial cabamiquine inhibits blood-stage of different field isolates of Plasmodium species. [PDF]

BMC Infect Dis
Dembele L, Aniweh Y, Soulama A, Sogore F, Diakité O, Diallo F, Dao F, Amenga-Etego LN, Demarta-Gatsi C, Spangenberg T, Djimde AA.   +10 more
europepmc   +1 more source

First TES in Djibouti: A Critical Milestone Amid Rising Regional Threats. [PDF]

Open Forum Infect Dis
Behaksra SW, Guelleh SK, Sisay S, Weldehana YA, Weyesa DM, Endale T, Hamad AA, Hundera NL, Alemayehu DH, Tafa EB, Louie W, Aranda-Diaz A, Shiferaw M, Ayele MK, Kassa FA, Lakew DH, Shimelash A, Kebede BA, Abdo M, Bezabih MK, Moussa YO, Tessema TS, Greenhouse B, Abdi AA, Khaireh BA, Tadesse FG.   +25 more
europepmc   +1 more source

Genotype Complexity Modulates Antimalarial Susceptibility in vitro. [PDF]

Infect Drug Resist
Egwu CO, Ajibaye O, Bojang F, Mbye H, Ntui-Njock VN, Drammeh NF, Oriero EC, Amambua-Ngwa A.   +7 more
europepmc   +1 more source

Severe malaria in pregnancy in the United States: A case report and management considerations. [PDF]

Case Rep Womens Health
Reyes Lizaola S, Kumari S, Di Francesco L, Chedid J, Cay Martinez C.   +4 more
europepmc   +1 more source

<i>Plasmodium falciparum</i> field isolates drug susceptibility in Mali. [PDF]

JAC Antimicrob Resist
Maiga FO, Dembele L, Dama S, Diakite O, Diallo F, Sogore F, Maiga M, Dao F, Dara N, Alhousseini ML, Traore OB, Djimde AA.   +11 more
europepmc   +1 more source

Artemether-lumefantrine versus pyronaridine-artesunate for the treatment of malaria in patients with mild to moderate COVID-19 in Kenya and Burkina Faso: a randomised open-label trial (MALCOV). [PDF]

EClinicalMedicine
Tangara B, Barsosio HC, Marlais T, Kabore JMT, Tiono AB, Otieno K, Wanjiku M, Achieng M, Onyango ED, Ondieki ED, Aura H, Odawo T, Allen DJ, Hannan L, Tetteh KK, Soulama I, Ouedraogo A, Serme SS, Soulama BI, Barry A, Badoum ES, Matthewman J, Brazal-Monzó H, Canizales J, Drabko A, Wu W, Kariuki S, Lesosky M, Sirima SB, Drakeley C, Ter Kuile FO.   +30 more
europepmc   +1 more source

A Controlled Human Malaria Infection model for relapsing Plasmodium vivax

Duncan AD, Geraedts TJ, Manlutac D, Baker EC, van Heerden JK, Roberts TW, Rigby CA, Salkeld J, Hou MM, Megson C, Kashojhala K, Boyle J, Nwankwo C, Williams BG, McHugh K, Teo ZW, Rodrigues AS, Gladstone CA, Comma E, Mujadidi YF, Robinson H, Plested E, McCall MB, Bousema T, Gmeiner M, Bok J, Graumans W, van Gemert G, Cowan RE, Boyd A, Ekregbesi P, Owino N, Cho J, Nugent FL, Nielsen CM, Mordmüller B, Donnellan FR, Silk SE, Draper SJ, Minassian AM.   +39 more
europepmc   +1 more source

Biomedical Properties, Developments and Therapeutic Potential of Sesquiterpenoid Lactones and Natural Compounds. [PDF]

Pharmaceuticals (Basel)
García-Hernández N, Ramírez-Sánchez I, Ordoñez-Razo RM.   +2 more
europepmc   +1 more source

National genomic profiling of Plasmodium falciparum antimalarial resistance in Zambian children participating in the 2018 malaria indicator survey. [PDF]

Sci Rep
Fola AA, Ciubotariu II, Dorman J, Mwenda MC, Mambwe B, Mulube C, Kasaro R, Hawela MB, Hamainza B, Miller JM, Bailey JA, Moss WJ, Bridges DJ, Carpi G.   +13 more
europepmc   +1 more source

Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020-2021. [PDF]

Malar J
Gansane A, Tarama C, Lingani M, Debe S, Tiendrebeogo F, Kinda R, Sagnon A, Ganou A, Rouamba T, Sombie S, Some H, Kiendrebeogo S, Bonko MA, Tougri G, Kompaore CS, Wiesner L, Eddis C, Horton B, Kennedy C, Bajic M, Pierre-Louis E, Kahn A, Rosillo S, Patel DS, McCaffery JN, Plucinski MM, Laird V, Ahmed J, Tinto H, Valea I, Moriarty LF.   +30 more
europepmc   +1 more source